Destination Therapy: Current Results and Future Promise

Seminars in Thoracic and Cardiovascular Surgery

Volumn 20, Issue 3, 2008, Pages 225-233

  Lietz, Katherine ^a   Miller, Leslie W ^b  

^a New York Presbyterian Hospital Columbia University Medical Center   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

advanced heart failure; ventricular assist devices

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INOTROPIC AGENT;

ARTICLE; ARTIFICIAL HEART; ASSISTED CIRCULATION; BLEEDING; CEREBROVASCULAR ACCIDENT; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; COST EFFECTIVENESS ANALYSIS; EQUIPMENT DESIGN; EUROPE; HEART ASSIST DEVICE; HEART FAILURE; HEART INDEX; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FAILURE; HIGH RISK PATIENT; HOSPITALIZATION COST; HUMAN; LENGTH OF STAY; MALNUTRITION; MORTALITY; MULTIPLE ORGAN FAILURE; PATIENT SELECTION; RISK ASSESSMENT; SEPSIS; SODIUM RESTRICTION; SURGICAL MORTALITY; SURGICAL RISK; SURVIVAL RATE; UNITED STATES;

CLINICAL TRIALS AS TOPIC; EQUIPMENT DESIGN; EUROPE; HEART FAILURE; HEART VENTRICLES; HEART-ASSIST DEVICES; HUMANS; PROSTHESIS IMPLANTATION; TREATMENT OUTCOME; UNITED STATES;

EID: 56349130226     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2008.08.004     Document Type: Article

References (33)

1. American Heart Association. Heart Disease and Stroke Statistics-2007 Update (2007), American Heart Association, Dallas, TX
2. Herschberger R.E., Nauman D., Walker T.L., et al. Care processes and clinical outcomes of Continuous Outpatient Support with Inotropes (COSI) in patients with refractory endstage heart failure. J Card Failure 9 (2003) 180-187
3. Stevenson L.W., and Couper G. On the fledgling field of mechanical circulatory support. J Am Coll Cardiol 50 (2007) 748-751
4. National population projections (2004), Consensus Bureau, Washington, DC. http://www.census.gov/ipc/www/usinterimproj/ Available at: http://www.census.gov/ipc/www/usinterimproj/. Accessed June 1, 2008
5. Rose E.A., Gelijns A.C., Moskowitz A.J., et al. Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) Study Group. Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 345 (2001) 1435-1443
6. Rogers J.G., Butler J., Lansman S.L., et al., INTrEPID Investigators. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID Trial. J Am Coll Cardiol 50 (2007) 741-747
7. Pae W.E., Connell J.M., Adelowo A., et al., Clinical Utility Baseline Study (CUBS) Group. Does total implantability reduce infection with the use of a left ventricular assist device?. The LionHeart experience in Europe. J Heart Lung Transplant 26 (2007) 219-229
8. Esmore D., Kaye D., Spratt P., et al. A prospective, multicenter trial of the VentrAssist left ventricular assist device for bridge to transplant: safety and efficacy. J Heart Lung Transplant 27 (2008) 579-588
9. Micromed Goldstein D.J. Worldwide experience with the MicroMed DeBakey Ventricular Assist Device as a bridge to transplantation. Circulation 108 (2003) 272-277
10. Siegenthaler M.P., Westaby S., Frazier O.H., et al. Advanced heart failure: feasibility study of long-term continuous axial flow pump support. Eur Heart J 26 (2005) 1031-1038
11. Dowling R.D., Gray L.A., Etoch S.W., et al. Initial experience with AbioCor implantable replacement heart system. J Thorac Cardiovasc Surg 127 (2004) 131-141
12. Dowling R.D., Park S.J., Pagani F.D., et al. HeartMate VE LVAS design enhancements and its impact on device reliability. Eur J Cardiothorac Surg 25 (2004) 958-963
13. Deng M.C., Young J.B., Stevenson L.W., et al., Board of Directors of the International Society for Heart and Lung Transplantation. Destination mechanical circulatory support: proposal for clinical standards. J Heart Lung Transplant 22 (2003) 365-369
14. Centers for Medicare and Medicaid Services (CMS). The National Coverage Determination for Artificial Hearts and Related Devices. Online Manual System, Section 20.9. http://www.cms.hhs.gov/manuals/downloads/ncd103c1_Part1.pdf Accessed March 1, 2008
15. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) Official Website. http://www.intermacs.org/membership.aspx Accessed February 28, 2007
16. Naftel D.C., Rogerjs J.G., Young J.B., et al. The use of Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) to generate objective performance criteria for use in MCSD trials. J Heart Lung Transplant 27 (2008) S167 (abstract)
17. Pagani F.D., Warner Stevenson L., et al. Pre-implant patient triage using patient status with INTERMACS patient profiles: can we refine selection strategy for MCS?. J Heart Lung Transplant 27 (2008) S60 (abstract)
18. Lietz K., Long J.W., Kfoury A.G., et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 116 (2007) 497-505
19. Miller L.W., and Lietz K. Candidate selection for long-term left ventricular assist device therapy for refractory heart failure. J Heart Lung Transplant 25 (2006) 756-756
20. Gracin N., Johnson M.R., Spokas D., et al. The use of APACHE II scores to select candidates for left ventricular assist device placement. Acute Physiology and Chronic Health Evaluation. J Heart Lung Transplant 17 (1998) 1017-1023
21. Joyce D.L., Conte J.V., Russell S.D., et al. Disparities in access to left ventricular assist device therapy. J Surg Res (2008) (in press)
22. Jurmann M.J., Weng Y., Drews T., et al. Permanent mechanical circulatory support in patients of advanced age. Eur J Cardio Thorac Surg 25 (2004) 610-618
23. Franco O.H., Steyerberg E.W., Hu F.B., et al. Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease. Arch Intern Med 167 (2007) 1145-1151
24. Young J.B., Rogers J.G., Portner P.M., et al. Bridge to eligibility: LVAS support in patients with relative contraindications to transplantation. J Heart Lung Transplant 24 (2005) S75
25. Miller L.W., Pagani F.D., Russell S.D., et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 357 (2007) 885-896
26. Park S.J., Tector A., Piccioni W., et al. Left ventricular assist devices as destination therapy: a new look at survival. J Thorac Cardiovasc Surg 129 (2005) 9-17
27. Long J.W., Kfoury A.G., Slaughter M.S., et al. Long-term destination therapy with the HeartMate XVE left ventricular assist device: improved outcomes since the REMATCH study. Congest Heart Fail 11 (2005) 133-138
28. Lazar R.M., Shapiro P.A., Jaski B.E., et al. Neurological events during long-term mechanical circulatory support for heart failure: the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) experience. Circulation 109 (2004) 2423-2427
29. Hutchinson J., Scott D.A., Clegg A.J., et al. Cost-effectiveness of left ventricular-assist devices in end-stage heart failure. Expert Rev Cardiovasc Ther 6 (2008) 175-185
30. Miller L.W., Nelson K.E., Bostic R.R., et al. Hospital costs for left ventricular assist devices for destination therapy: lower costs for implantation in the post-REMATCH era. J Heart Lung Transplant 25 (2006) 778-784
31. Benish L.A., Entwistle J.W., Hankins S.R., et al. Ethical consideration for cardiac ventricular assist device support: a 12 point protocol. J Heart Lung Transplant 27 (2008) S232 (abstract)
32. Brush S.J., Kfoury A.G., Healy A.H., et al. Participation in end of life decisions with destination left ventricular assist device therapy. J Heart Lung Transplant 26 (2008) S181 (abstract)
33. Coyle L.A., Martin M.M., Kurien S., et al. Destination therapy: safety and feasibility of national and international travel. ASAIO J 54 (2008) 172-176